Overview

TNF Alpha in Refractory Asthma

Status:
Completed

Trial end date:
2004-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to investigate whether the administration of etanercept to patients with severe asthma improved their asthma related quality of life and a measure of the degree of reactivity of the airways

Phase:

N/A

Details

Lead Sponsor:

University Hospitals, Leicester

Treatments:

Etanercept